Lin Hang, Zhang Heng, Cheng Yuanda, Zhang Chunfang
Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Human Engineering Research Center for Pulmonary Nodules Precise Diagnosis and Treatment, Xiangya Hospital, Central South University, Changsha, China.
Front Oncol. 2020 Dec 17;10:593142. doi: 10.3389/fonc.2020.593142. eCollection 2020.
Renal cell carcinoma can metastasize to virtually any anatomical site throughout the body, especially the lung, bone, lymph nodes, liver, and brain. However, it is extremely rare for renal cell carcinoma to metastasize solely to the mediastinal lymph node more than 15 years after radical nephrectomy.
The case we present here is that of a 50-year-old Chinese male with an isolated posterior mediastinal lymph node metastasis of clear cell renal cell carcinoma 16 years after radical nephrectomy. However, based on imaging examination, the mass was clinically misdiagnosed as Castleman's disease before operation. Following surgical excision of the mass, it was finally judged to be a metastasis from clear cell renal cell carcinoma according to the patient's medical history and immunohistochemical findings. Currently, there is no clinical or radiological finding the recurrence of metastasis after 10 months of follow-up.
We report a case of solitary metastasis in the posterior mediastinal lymph node 16 years after radical nephrectomy for clear cell renal cell carcinoma. Given the long disease-free interval between primary renal cell carcinoma to isolated mediastinal lymph node metastasis, it is important to conduct a lifelong regular follow-up, including thoracic computed tomography. In addition, surgical resection remains the best method of treatment for mediastinal lymph node metastases from clear cell renal cell carcinoma if the metastatic lesion is limited.
肾细胞癌几乎可转移至全身任何解剖部位,尤其是肺、骨、淋巴结、肝和脑。然而,在根治性肾切除术后15年以上,肾细胞癌仅转移至纵隔淋巴结极为罕见。
我们在此呈现的病例是一名50岁中国男性,在根治性肾切除术后16年出现孤立性后纵隔淋巴结转移的透明细胞肾细胞癌。然而,基于影像学检查,该肿块在术前被临床误诊为Castleman病。在手术切除肿块后,根据患者病史和免疫组化结果最终判定为透明细胞肾细胞癌转移。目前,随访10个月后无临床或影像学复发转移表现。
我们报告了一例透明细胞肾细胞癌根治性肾切除术后16年出现后纵隔淋巴结孤立转移的病例。鉴于原发性肾细胞癌至孤立性纵隔淋巴结转移之间存在较长的无病间期,进行包括胸部计算机断层扫描在内的终身定期随访很重要。此外,如果转移病灶局限,手术切除仍是治疗透明细胞肾细胞癌纵隔淋巴结转移的最佳方法。